Are you Dr. Styles?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
747 52nd Street
Oakland, CA 94609Phone+1 510-428-3372Fax+1 510-601-3916- Is this information wrong?
Summary
- Dr. Lori Styles, MD is a pediatric hematologist/oncologist in Oakland, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Benioff Children's Hospital Oakland, Alta Bates Summit Medical Center-Alta Bates Campus, and John Muir Medical Center, Walnut Creek.
Education & Training
Children's Hospital-OaklandFellowship, Pediatric Hematology/Oncology, 1993 - 1996- Children's Hospital-OaklandResidency, Pediatrics, 1989 - 1992
University of California San Diego School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2016
Clinical Trials
- Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients Start of enrollment: 2001 Aug 01
- Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease Start of enrollment: 2012 Feb 01
- Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease Start of enrollment: 2014 Jul 14
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsIbrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, Jörn C Albring, Mary Flowers, Alan P Skarbnik, Ibrahim Yakoub-Agha, Bor-Sheng Ko, Benedetto Bruno, Edmund K W...> ;Journal of Clinical Oncology. 2023 Apr 1
- 368 citationsIbrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, ope...Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, Loree Larratt, Martin Simkovic, Olga Samoilova, Jan Novák, Dina Ben-Yehuda, Vladimir St...> ;The Lancet. Oncology. 2019 Jan 1
- 21 citationsSingle-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studiesTadeusz Robak, Jan A. Burger, Alessandra Tedeschi, Paul M. Barr, Carolyn Owen, Osnat Bairey, Peter Hillmen, David Simpson, Sebastian Grosicki, Stephen Devereux, Helen ...> ;American Journal of Hematology. 2018 Nov 1
- Join now to see all
Press Mentions
FDA Accepts Ibrutinib Application for GVHDApril 4th, 2017
Hospital Affiliations
UCSF Benioff Children's Hospital OaklandOakland, California
Alta Bates Summit Medical Center-Alta Bates CampusBerkeley, California
John Muir Medical Center, Walnut CreekWalnut Creek, California
Providence Queen of the Valley Medical CenterNapa, California
